{
    "document": "MSFT_0001564590-20-034944",
    "field": "Stock repurchases",
    "items": [
        "10_Item_8__Financial_Statements_and_Supplementary_Data"
    ],
    "combined_text": "year 2021. 85 PART II Item 8 Other Contingencies We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving claims against us, individually or in aggregate, will not have a material adverse impact in our consolidated financial statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. As of June 30, 2020, we accrued aggregate legal liabilities of $306 million. While we intend to defend these matters vigorously, adverse outcomes\n\nthat we estimate could reach approximately $500 million in aggregate beyond recorded amounts are reasonably possible. Were unfavorable final outcomes to occur, there exists the possibility of a material adverse impact in our consolidated financial statements for the period in which the effects become reasonably estimable. NOTE 16 — STOCKHOLDERS’ EQUITY Shares Outstanding Shares of common stock outstanding were as follows: (In millions) Year Ended June 30, 2020 2019 2018 Balance, beginning of year 7,643 7,677 7,708 Issued 54 116 68 Repurchased (126) (150) (99) Balance, end of year 7,571 7,643 7,677 Share Repurchases On September 20, 2016, our Board\n\nof Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in December 2016 and was completed in February 2020. On September 18, 2019, our Board of Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in February 2020, following completion of the program approved on September 20, 2016, has no expiration date, and may be terminated at any time. As of June 30, 2020, $31.7 billion remained of this $40.0 billion share repurchase program. 86 PART II Item 8 We\n\nrepurchased the following shares of common stock under the share repurchase programs: (In millions) Shares Amount Shares Amount Shares Amount Year Ended June 30, 2020 2019 2018 First Quarter 29 $ 4,000 24 $ 2,600 22 $ 1,600 Second Quarter 32 4,600 57 6,100 22 1,800 Third Quarter 37 6,000 36 3,899 34 3,100 Fourth Quarter 28 5,088 33 4,200 21 2,100 Total 126 $ 19,688 150 $ 16,799 99 $ 8,600 Shares repurchased during the fourth quarter of fiscal year 2020 were under the share repurchase program approved on September 18, 2019. Shares repurchased during the third quarter of\n\nfiscal year 2020 were under the share repurchase programs approved on both September 20, 2016 and September 18, 2019. All other shares repurchased were under the share repurchase program approved on September 20, 2016. The above table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards of $3.3 billion, $2.7 billion, and $2.1 billion for fiscal years 2020, 2019, and 2018, respectively. All share repurchases were made using cash resources. Dividends Our Board of Directors declared the following dividends: Dividend Declaration Date Record Date Payment Date Per Share Amount Fiscal Year 2020 (In millions)\n\nthat we estimate could reach approximately $500 million in aggregate beyond recorded amounts are reasonably possible. Were unfavorable final outcomes to occur, there exists the possibility of a material adverse impact in our consolidated financial statements for the period in which the effects become reasonably estimable. NOTE 16 — STOCKHOLDERS’ EQUITY Shares Outstanding Shares of common stock outstanding were as follows: (In millions) Year Ended June 30, 2020 2019 2018 Balance, beginning of year 7,643 7,677 7,708 Issued 54 116 68 Repurchased (126) (150) (99) Balance, end of year 7,571 7,643 7,677 Share Repurchases On September 20, 2016, our Board\n\nof Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in December 2016 and was completed in February 2020. On September 18, 2019, our Board of Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in February 2020, following completion of the program approved on September 20, 2016, has no expiration date, and may be terminated at any time. As of June 30, 2020, $31.7 billion remained of this $40.0 billion share repurchase program. 86 PART II Item 8 We\n\nrepurchased the following shares of common stock under the share repurchase programs: (In millions) Shares Amount Shares Amount Shares Amount Year Ended June 30, 2020 2019 2018 First Quarter 29 $ 4,000 24 $ 2,600 22 $ 1,600 Second Quarter 32 4,600 57 6,100 22 1,800 Third Quarter 37 6,000 36 3,899 34 3,100 Fourth Quarter 28 5,088 33 4,200 21 2,100 Total 126 $ 19,688 150 $ 16,799 99 $ 8,600 Shares repurchased during the fourth quarter of fiscal year 2020 were under the share repurchase program approved on September 18, 2019. Shares repurchased during the third quarter of\n\nfiscal year 2020 were under the share repurchase programs approved on both September 20, 2016 and September 18, 2019. All other shares repurchased were under the share repurchase program approved on September 20, 2016. The above table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards of $3.3 billion, $2.7 billion, and $2.1 billion for fiscal years 2020, 2019, and 2018, respectively. All share repurchases were made using cash resources. Dividends Our Board of Directors declared the following dividends: Dividend Declaration Date Record Date Payment Date Per Share Amount Fiscal Year 2020 (In millions)\n\nSeptember 18, 2019 November 21, 2019 December 12, 2019 $ 0.51 $ 3,886 December 4, 2019 February 20, 2020 March 12, 2020 0.51 3,876 March 9, 2020 May 21, 2020 June 11, 2020 0.51 3,865 June 17, 2020 August 20, 2020 September 10, 2020 0.51 3,861 Total $ 2.04 $ 15,488 Fiscal Year 2019 September 18, 2018 November 15, 2018 December 13, 2018 $ 0.46 $ 3,544 November 28, 2018 February 21, 2019 March 14, 2019 0.46 3,526 March 11, 2019 May 16, 2019 June 13, 2019 0.46 3,521 June 12, 2019 August 15, 2019 September 12, 2019 0.46 3,510\n\ngeneral causation experts. The defendants filed an interlocutory appeal to the District of Columbia Court of Appeals challenging the standard for evaluating expert scientific evidence. In October 2016, the Court of Appeals issued its decision adopting the standard advocated by the defendants and remanding the cases to the trial court for further proceedings under that standard. The plaintiffs have filed supplemental expert evidence, portions of which the defendants have moved to strike. In August 2018, the trial court issued an order striking portions of the plaintiffs’ expert reports. A hearing is expected to occur in the second quarter of fiscal\n\nyear 2021. 85 PART II Item 8 Other Contingencies We also are subject to a variety of other claims and suits that arise from time to time in the ordinary course of our business. Although management currently believes that resolving claims against us, individually or in aggregate, will not have a material adverse impact in our consolidated financial statements, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. As of June 30, 2020, we accrued aggregate legal liabilities of $306 million. While we intend to defend these matters vigorously, adverse outcomes\n\nthat we estimate could reach approximately $500 million in aggregate beyond recorded amounts are reasonably possible. Were unfavorable final outcomes to occur, there exists the possibility of a material adverse impact in our consolidated financial statements for the period in which the effects become reasonably estimable. NOTE 16 — STOCKHOLDERS’ EQUITY Shares Outstanding Shares of common stock outstanding were as follows: (In millions) Year Ended June 30, 2020 2019 2018 Balance, beginning of year 7,643 7,677 7,708 Issued 54 116 68 Repurchased (126) (150) (99) Balance, end of year 7,571 7,643 7,677 Share Repurchases On September 20, 2016, our Board\n\nof Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in December 2016 and was completed in February 2020. On September 18, 2019, our Board of Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in February 2020, following completion of the program approved on September 20, 2016, has no expiration date, and may be terminated at any time. As of June 30, 2020, $31.7 billion remained of this $40.0 billion share repurchase program. 86 PART II Item 8 We\n\nrepurchased the following shares of common stock under the share repurchase programs: (In millions) Shares Amount Shares Amount Shares Amount Year Ended June 30, 2020 2019 2018 First Quarter 29 $ 4,000 24 $ 2,600 22 $ 1,600 Second Quarter 32 4,600 57 6,100 22 1,800 Third Quarter 37 6,000 36 3,899 34 3,100 Fourth Quarter 28 5,088 33 4,200 21 2,100 Total 126 $ 19,688 150 $ 16,799 99 $ 8,600 Shares repurchased during the fourth quarter of fiscal year 2020 were under the share repurchase program approved on September 18, 2019. Shares repurchased during the third quarter of"
}